Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Monitoring of Plasma Ferritin Levels after Blood Transfusions in Patients with Myelodysplastic Syndromes

Johanne Rozema, Ivar Van Asten, Beau Kwant, Robby E Kibbelaar, Nic J.G.M. Veeger, Harry De Wit, Eric N. Van Roon, Mels Hoogendoorn

Blood (2021) 138 (Supplement 1): 1986.

https://doi.org/10.1182/blood-2021-152096

Published: 2021

Journal Articles

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study

Berdien Oortgiesen, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Robby Kibbelaar, MD PhD, Huib Storm, PhD, Sjoerd Hovenga, MDPhD, Bas P Van Rees, MD PhD, Gerhard Woolthuis, MD, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD PhD

Blood (2014) 124 (21): 2136.

https://doi.org/10.1182/blood.V124.21.2136.2136

Published: 2014

Journal Articles

Clinical Outcome After Occurrence Of Vitamin K-Antagonist Related Major Bleeding Complication: A Two-Year Observational Follow-Up Study

Nakisa Khorsand, Pharm D, Reinier M van Hest, Pharm D, PhD, Shakiba Zahedin Labbaf, MSc, Paula Ypma, MD, Helga W Vermaas, MD, Nic J.G.M. Veeger, PhD, Karina Meijer, MD PhD

Blood (2013) 122 (21): 2382.

https://doi.org/10.1182/blood.V122.21.2382.2382

Published: 2013

Journal Articles

A Cohort Study Of 15,912 Patients On The Long-Term Quality Of Vka Therapy After Extreme Overanticoagulation

Hilde A.M. Kooistra, MD, Nakisa Khorsand, PharmD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Margriet Piersma, MD, Karina Meijer, MD, PhD

Blood (2013) 122 (21): 2384.

https://doi.org/10.1182/blood.V122.21.2384.2384

Published: 2013

Journal Articles

A Systematic Review On Different Prothrombin Complex Concentrate Strategies To Reverse Vitamin K Antagonist Therapy

Nakisa Khorsand, Pharm D, Hilde A.M. Kooistra, MD, Reinier M. van Hest, Pharm D, PhD, Nic J.G.M. Veeger, PhD, Karina Meijer, MD PhD

Blood (2013) 122 (21): 3639.

https://doi.org/10.1182/blood.V122.21.3639.3639

Published: 2013

Journal Articles

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.

Karin Boslooper, Peter Joosten, MD, Nic J.G.M. Veeger, PhD, Robby Kibbelaar, MD, PhD, Eric van Roon, Sjoerd Hovenga, Gerhard Woolthuis, MD, Hanneke C. Kluin-Nelemans, Mels Hoogendoorn, MD, PhD

Blood (2012) 120 (21): 2642.

https://doi.org/10.1182/blood.V120.21.2642.2642

Published: 2012

Journal Articles

Change in Body-Mass-Index and Persisting Symptoms After Pulmonary Embolism

Anja B.U. Mäkelburg, MD, Elke S. Hoendermis, MD PhD, Nic J.G.M. Veeger, PhD, J.C. Kluin-Nelemans, Karina Meijer, MD PhD

Blood (2012) 120 (21): 3389.

https://doi.org/10.1182/blood.V120.21.3389.3389

Published: 2012

Journal Articles

Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

André Wieringa, PharmD, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Tim Beerden, B.Sc, Huib Storm, PhD, Robby Kibbelaar, MD, PhD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD, PhD

Blood (2012) 120 (21): 3656.

https://doi.org/10.1182/blood.V120.21.3656.3656

Published: 2012

Journal Articles

Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program,

Blood (2011) 118 (21): 3841.

https://doi.org/10.1182/blood.V118.21.3841.3841

Published: 2011

Journal Articles

Associations Between Free Protein S and Factor VIII Levels with Traditional Arterial Thrombotic Risk Factors and Their Risk On Arterial Thrombosis. Results From a Retrospective Family Cohort Study.

René Mulder, Inge M van Schouwenburg, Bakhtawar Khan Mahmoodi, Nic J.G.M. Veeger, André B Mulder, MD, Saskia Middeldorp, MD, PhD, Hanneke C. Kluin-Nelemans, Willem M Lijfering, MD

Blood (2009) 114 (22): 25.

https://doi.org/10.1182/blood.V114.22.25.25

Published: 2009

Journal Articles

Hereditary Deficiencies of Protein C or Protein S Confer Increased Risk of Arterial Thromboembolic Events at Young Age. Results from a Large Family Cohort Study

Bakhtawar Khan Mahmoodi, Jan-Leendert P. Brouwer, Nic J.G.M. Veeger, Jan van der Meer

Blood (2008) 112 (11): 422.

https://doi.org/10.1182/blood.V112.11.422.422

Published: 2008

Journal Articles

Early Minor Bleeding as Risk Indicator for Major Bleeding in Patients Using Vitamin-K-Antagonists, Independent of Quality of Anticoagulation.

Nic J.G.M. Veeger, Margriet Piersma-Wichers, Hans L. Hillege, Jan van der Meer

Blood (2008) 112 (11): 987.

https://doi.org/10.1182/blood.V112.11.987.987

Published: 2008

Journal Articles

Microalbuminuria Is Associated with An Increased Risk of Venous Thromboembolism. A Novel Risk Marker for Venous Thromboembolism

Bakhtawar Khan Mahmoodi, Ron T. Gansevoor, Nic J.G.M. Veeger, Hans L. Hillege, Gerjan Navis, Jan van der Meer

Blood (2008) 112 (11): 523.

https://doi.org/10.1182/blood.V112.11.523.523

Published: 2008

Journal Articles

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

Hendrika M Knol, Nic J.G.M. Veeger, Saskia Middeldorp, Karly Hamulyàk, Martin H Prins, Harry R Büller, Jan van der Meer

Blood (2008) 112 (11): 1815.

https://doi.org/10.1182/blood.V112.11.1815.1815

Published: 2008

Journal Articles

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Willem M. Lijfering, MD, Michiel Coppens, MD, Nic J.G.M. Veeger, MSc, Saskia Middeldorp, MD, PhD, Karly Hamulyak, MD, PhD, Martin H. Prins, MD, Phd, Harry R. Buller, MD, PhD, Jan van der Meer, Md, PhD

Blood (2007) 110 (11): 130.

https://doi.org/10.1182/blood.V110.11.130.130

Published: 2007

Journal Articles

Risk of Venous Thromboembolism Is Not Increased by Elevated TAFI Levels.

Nienke Folkeringa, MD, Jan Leendert P. Brouwer, MD, Nic J.G.M Veeger, MSc, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1484.

https://doi.org/10.1182/blood.V108.11.1484.1484

Published: 2006

Journal Articles

Methionine-Loading and Random Homocysteine Tests Have No Added Value in Risk Assessment for Venous and Arterial Thrombosis.

Willem M. Lijfering, MD, Nic J.G.M. Veeger, MSc, Jan-Leendert P. Brouwer, MD, Marlene H.W. van de Poel, MD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1486.

https://doi.org/10.1182/blood.V108.11.1486.1486

Published: 2006

Journal Articles

High Risk of Pregnancy Related Venous Thromboembolism in Women with a Hereditary Deficiency of Antithrombin, Protein C or Protein S in Concomitance of Other Thrombophilic Defects: A Retrospective Cohort Study.

Nienke Folkeringa, MD, Jan-Leendert P. Brouwer, MD, Fleurisca J. Korteweg, MD, Nic J.G.M Veeger, MSc, Jan Jaap H.M. Erwich, MD PhD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1485.

https://doi.org/10.1182/blood.V108.11.1485.1485

Published: 2006

Journal Articles

Tendency towards Minor Bleeding in Women Is Associated with a Reduced Risk for Major Bleeding, without Apparent Differences in Level of Anticoagulation during Treatment with Vitamin K Antagonist.

Nic J.G.M. Veeger, MSc, Margriet Piersma-Wichers, MD, Jan van der Meer, MD, PhD

Blood (2006) 108 (11): 889.

https://doi.org/10.1182/blood.V108.11.889.889

Published: 2006

Journal Articles

The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects Is Caused by Elevated Factor VIII:C Levels.

Willem M. Lijfering, MD, Nic J.G.M. Veeger, MSc, Jan-Leendert P. Brouwer, MD, Marlene H.W. van de Poel, MD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 273.

https://doi.org/10.1182/blood.V108.11.273.273

Published: 2006

NARROW

Monitoring of Plasma Ferritin Levels after Blood Transfusions in Patients with Myelodysplastic Syndromes

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study

Clinical Outcome After Occurrence Of Vitamin K-Antagonist Related Major Bleeding Complication: A Two-Year Observational Follow-Up Study

A Cohort Study Of 15,912 Patients On The Long-Term Quality Of Vka Therapy After Extreme Overanticoagulation

A Systematic Review On Different Prothrombin Complex Concentrate Strategies To Reverse Vitamin K Antagonist Therapy

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.

Change in Body-Mass-Index and Persisting Symptoms After Pulmonary Embolism

Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program,

Associations Between Free Protein S and Factor VIII Levels with Traditional Arterial Thrombotic Risk Factors and Their Risk On Arterial Thrombosis. Results From a Retrospective Family Cohort Study.

Hereditary Deficiencies of Protein C or Protein S Confer Increased Risk of Arterial Thromboembolic Events at Young Age. Results from a Large Family Cohort Study

Early Minor Bleeding as Risk Indicator for Major Bleeding in Patients Using Vitamin-K-Antagonists, Independent of Quality of Anticoagulation.

Microalbuminuria Is Associated with An Increased Risk of Venous Thromboembolism. A Novel Risk Marker for Venous Thromboembolism

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Risk of Venous Thromboembolism Is Not Increased by Elevated TAFI Levels.

Methionine-Loading and Random Homocysteine Tests Have No Added Value in Risk Assessment for Venous and Arterial Thrombosis.

High Risk of Pregnancy Related Venous Thromboembolism in Women with a Hereditary Deficiency of Antithrombin, Protein C or Protein S in Concomitance of Other Thrombophilic Defects: A Retrospective Cohort Study.

Tendency towards Minor Bleeding in Women Is Associated with a Reduced Risk for Major Bleeding, without Apparent Differences in Level of Anticoagulation during Treatment with Vitamin K Antagonist.

The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects Is Caused by Elevated Factor VIII:C Levels.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only